Impact of copper-coated surfaces on healthcare-associated infections and microbial load in a pediatric tertiary care setting: an observational cohort study
Infection Control & Hospital Epidemiology · 2026
DOI: 10.1017/ice.2026.10476 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Infection Control & Hospital Epidemiology, 2026. Verfasst von Quentin Michalchuk und 7 weiteren Autor:innen. Beteiligte Einrichtung: The University of British Columbia, Canada. Hauptthemen laut MEDLINE: Cross Infection, Copper. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the effect of copper-coated high-touch surfaces on environmental microbial burden and healthcare-associated infection (HAI) rates.
Design
Observational cohort study over 20 months.
Setting
Pediatric intensive care and oncology inpatient units in a tertiary care hospital.
Participants
All patients admitted to rooms with or without copper-coated surfaces. Exposure: Spray-on copper coating applied to high-touch surfaces in patient rooms.
Methods
Patients were admitted to rooms according to routine hospital practices. Demographic and clinical data were collected for a subset of patients admitted to rooms with copper-coated surfaces and matching control rooms. Environmental samples were collected from high-touch surfaces to quantify bacterial colony counts. HAIs were identified via a surveillance database and reported per 10,000 patient days. Poisson regression and negative binomial mixed-effects model were used for analysis.
Results
Patients in copper-coated rooms were more likely to have an infection on admission (29.7% vs 2.9%; P = .003). Bacterial colony counts trended lower in copper-coated rooms (rate ratio (RR) 0.74, 95% CI 0.50–1.08; P = .11; absolute rate difference −12.25, 95% CI −26.12–2.10), with variability by surface type. HAI rates trended higher in copper-coated rooms compared to control rooms (48.2 vs 30.5 per 10,000 patient days; RR 1.58, 95% CI 0.78–3.20; P = .20).
Conclusions
Copper-coated surfaces were not associated with statistically significant reductions in microbial burden or HAI rates. Contributing factors may include low baseline microbial load, low baseline HAI rates, variable copper alloy efficacy, short study duration, and differences between patients in intervention and control rooms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The University of British Columbia, Canada.
- BC Children's Hospital Research Institute, Canada.
- Provincial Health Services Authority, Canada.
- BC Children's & BC Women's Hospitals, Vancouver, British Columbia, Canada.
- Royal Alexandra Hospital, Canada.
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
ORCID-Profile: Quentin Michalchuk, Qian Zhang, Susanna Piasecki, David M Goldfarb, Jocelyn A Srigley
Zitieren
APA
Michalchuk, Q., Zhang, Q., Collet, J. C., Piasecki, S., Walker, C., Wong, T., Goldfarb, D. M., & Srigley, J. A. (2026). Impact of copper-coated surfaces on healthcare-associated infections and microbial load in a pediatric tertiary care setting: an observational cohort study. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2026.10476
Vancouver
Michalchuk Q, Zhang Q, Collet JC, Piasecki S, Walker C, Wong T, et al. Impact of copper-coated surfaces on healthcare-associated infections and microbial load in a pediatric tertiary care setting: an observational cohort study. Infection Control & Hospital Epidemiology. 2026. doi:10.1017/ice.2026.10476
BibTeX
@article{Michalchuk2026,
author = {Michalchuk, Quentin and Zhang, Qian and Collet, Jun C and Piasecki, Susanna and Walker, Celia and Wong, Titus and Goldfarb, David M and Srigley, Jocelyn A},
title = {Impact of copper-coated surfaces on healthcare-associated infections and microbial load in a pediatric tertiary care setting: an observational cohort study},
journal = {Infection Control & Hospital Epidemiology},
year = {2026},
doi = {10.1017/ice.2026.10476}
}
EUVIMED